Vanguard Group’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $6.63B | Buy |
83,947,987
+1,026,985
| +1% | +$80.5M | 0.1% | 185 |
|
|
2025
Q3 | $6.63B | Buy |
82,921,002
+169,313
| +0.2% | +$14.4M | 0.1% | 182 |
|
|
2025
Q2 | $7.52B | Buy |
82,751,689
+993,432
| +1% | +$90.7M | 0.12% | 144 |
|
|
2025
Q1 | $7.66B | Buy |
81,758,257
+455,198
| +0.6% | +$40.8M | 0.14% | 125 |
|
|
2024
Q4 | $7.39B | Buy |
81,303,059
+588,230
| +0.7% | +$56.1M | 0.13% | 129 |
|
|
2024
Q3 | $8.38B | Buy |
80,714,829
+397,957
| +0.5% | +$40.6M | 0.15% | 116 |
|
|
2024
Q2 | $7.79B | Buy |
80,316,872
+693,287
| +0.9% | +$64M | 0.15% | 115 |
|
|
2024
Q1 | $7.17B | Sell |
79,623,585
-270,759
| -0.3% | -$22.9M | 0.14% | 126 |
|
|
2023
Q4 | $6.37B | Buy |
79,894,344
+416,853
| +0.5% | +$31.3M | 0.14% | 131 |
|
|
2023
Q3 | $5.65B | Sell |
79,477,491
-224,099
| -0.3% | -$16.8M | 0.14% | 126 |
|
|
2023
Q2 | $6.14B | Sell |
79,701,590
-751,050
| -0.9% | -$58.1M | 0.15% | 121 |
|
|
2023
Q1 | $6.05B | Buy |
80,452,640
+77,629
| +0.1% | +$5.77M | 0.15% | 116 |
|
|
2022
Q4 | $6.33B | Buy |
80,375,011
+1,736,742
| +2% | +$130M | 0.17% | 108 |
|
|
2022
Q3 | $5.52B | Buy |
78,638,269
+882,517
| +1% | +$69.2M | 0.16% | 109 |
|
|
2022
Q2 | $6.23B | Buy |
77,755,752
+560,049
| +0.7% | +$43.8M | 0.18% | 97 |
|
|
2022
Q1 | $5.85B | Buy |
77,195,703
+449,089
| +0.6% | +$35.6M | 0.14% | 120 |
|
|
2021
Q4 | $6.55B | Buy |
76,746,614
+532,105
| +0.7% | +$41.6M | 0.15% | 114 |
|
|
2021
Q3 | $5.76B | Buy |
76,214,509
+1,629,741
| +2% | +$129M | 0.14% | 116 |
|
|
2021
Q2 | $6.07B | Buy |
74,584,768
+246,547
| +0.3% | +$20.2M | 0.15% | 108 |
|
|
2021
Q1 | $5.86B | Sell |
74,338,221
-1,318,965
| -2% | -$103M | 0.16% | 108 |
|
|
2020
Q4 | $6.47B | Sell |
75,657,186
-558,779
| -0.7% | -$46.2M | 0.19% | 89 |
|
|
2020
Q3 | $5.88B | Sell |
76,215,965
-911,415
| -1% | -$69.5M | 0.19% | 88 |
|
|
2020
Q2 | $5.65B | Sell |
77,127,380
-2,836,154
| -4% | -$201M | 0.2% | 87 |
|
|
2020
Q1 | $5.31B | Buy |
79,963,534
+1,934,246
| +2% | +$136M | 0.23% | 81 |
|
|
2019
Q4 | $5.37B | Buy |
78,029,288
+763,228
| +1% | +$52M | 0.18% | 97 |
|
|
2019
Q3 | $5.68B | Buy |
77,266,060
+763,220
| +1% | +$55.4M | 0.21% | 87 |
|
|
2019
Q2 | $5.48B | Buy |
76,502,840
+1,056,530
| +1% | +$75M | 0.21% | 85 |
|
|
2019
Q1 | $5.17B | Buy |
75,446,310
+141,752
| +0.2% | +$9.16M | 0.2% | 86 |
|
|
2018
Q4 | $4.48B | Buy |
75,304,558
+1,783,664
| +2% | +$112M | 0.2% | 89 |
|
|
2018
Q3 | $4.92B | Buy |
73,520,894
+734,860
| +1% | +$48.9M | 0.19% | 89 |
|
|
2018
Q2 | $4.72B | Buy |
72,786,034
+3,499,575
| +5% | +$229M | 0.2% | 82 |
|
|
2018
Q1 | $4.97B | Sell |
69,286,459
-51,715
| -0.1% | -$3.72M | 0.22% | 78 |
|
|
2017
Q4 | $5.23B | Buy |
69,338,174
+683,270
| +1% | +$49.9M | 0.23% | 75 |
|
|
2017
Q3 | $5B | Buy |
68,654,904
+779,520
| +1% | +$56.2M | 0.23% | 77 |
|
|
2017
Q2 | $5.03B | Buy |
67,875,384
+1,621,392
| +2% | +$120M | 0.25% | 71 |
|
|
2017
Q1 | $4.85B | Buy |
66,253,992
+2,590,036
| +4% | +$181M | 0.25% | 71 |
|
|
2016
Q4 | $4.17B | Buy |
63,663,956
+1,145,931
| +2% | +$78.6M | 0.23% | 77 |
|
|
2016
Q3 | $4.64B | Buy |
62,518,025
+1,678,541
| +3% | +$124M | 0.27% | 62 |
|
|
2016
Q2 | $4.45B | Buy |
60,839,484
+1,103,235
| +2% | +$78.6M | 0.28% | 63 |
|
|
2016
Q1 | $4.22B | Buy |
59,736,249
+2,007,121
| +3% | +$134M | 0.27% | 61 |
|
|
2015
Q4 | $3.85B | Buy |
57,729,128
+1,122,379
| +2% | +$74.7M | 0.26% | 69 |
|
|
2015
Q3 | $3.59B | Buy |
56,606,749
+1,789,334
| +3% | +$117M | 0.26% | 67 |
|
|
2015
Q2 | $3.59B | Buy |
54,817,415
+314,350
| +0.6% | +$21.3M | 0.24% | 70 |
|
|
2015
Q1 | $3.78B | Buy |
54,503,065
+316,983
| +0.6% | +$21.9M | 0.26% | 70 |
|
|
2014
Q4 | $3.75B | Buy |
54,186,082
+1,591,662
| +3% | +$107M | 0.27% | 67 |
|
|
2014
Q3 | $3.43B | Buy |
52,594,420
+586,559
| +1% | +$38.7M | 0.27% | 65 |
|
|
2014
Q2 | $3.55B | Buy |
52,007,861
+804,472
| +2% | +$53.9M | 0.28% | 60 |
|
|
2014
Q1 | $3.32B | Sell |
51,203,389
-214,886
| -0.4% | -$13.5M | 0.28% | 59 |
|
|
2013
Q4 | $3.35B | Buy |
51,418,275
+800,484
| +2% | +$51.2M | 0.29% | 58 |
|
|
2013
Q3 | $3B | Buy |
50,617,791
+967,033
| +2% | +$57.3M | 0.29% | 60 |
|
|
2013
Q2 | $2.84B | Buy |
+49,650,758
| New | +$2.95B | 0.3% | 59 |
|
Other funds holding CL
Vanguard Group's CL Position: Q4 2025 in Review
Vanguard Group increased its Colgate-Palmolive (CL) stake by 1.2% in Q4 2025, buying an estimated $80.5M and bringing the position to 83,947,987 shares worth $6.63B. The position accounts for 0.1% of the portfolio, ranked #185.
Vanguard Group first reported a position in CL in Q2 2013 and has held it in 51 quarters since. The position peaked at $8.38B in Q3 2024. 1,888 funds tracked by Wall St. Rank hold CL as of Q4 2025.
- Vanguard Group held 83,947,987 shares of Colgate-Palmolive worth $6.63B as of Q4 2025.
- Vanguard Group bought 1,026,985 Colgate-Palmolive shares in Q4 2025, an estimated $80.5M.
- Colgate-Palmolive made up 0.1% of Vanguard Group's portfolio in Q4 2025, its #185 holding.
- Vanguard Group first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 51 quarters since.
- Vanguard Group's Colgate-Palmolive position peaked at $8.38B in Q3 2024.
- 1,888 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q4 2025.
Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.